Article
OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.
International journal of molecular sciences - 27 Mar 2017
Hajj Aline, Halepian Lucine, Osta Nada El, Chahine Georges, Kattan Joseph, Rabbaa Khabbaz Lydia
Abstract excerpt
Despite increased attention on assessment and management, pain remains the most persistent symptom in patients with cancer, in particular in end-of-life settings, with detrimental impact on their quality-of-life (QOL). We conducted this study to evaluate the added value of determining some genetic and non-genetic factors to optimize cancer pain treatment. Eighty-nine patients were included in the study for the...
Topics
Join the communities discussing this publication.